Who is sponsoring NCT06126484?

NCT06126484 is sponsored by Sohag University.

What drugs are being tested in NCT06126484?

Interventions in NCT06126484: transcatheter cardiac intervention.

What condition does NCT06126484 study?

NCT06126484 studies Transcatheter Neonatal Cardiac Interventions.

Is NCT06126484 still recruiting?

NCT06126484 is currently status unknown. Last updated 13 November 2023.

Last reviewed 2023-11-13 · How we verify

NCT06126484

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Neonatal Transcatheter Cardiac Interventions at Sohag University Hospital

Status unknown NA Last updated 13 November 2023

What this trial tests

NA trial testing transcatheter cardiac intervention in Transcatheter Neonatal Cardiac Interventions in 30 participants. Status unknown.

Timeline

1 April 2023

Primary endpoint
1 April 2025

30 April 2025

Quick facts

Lead sponsor	Sohag University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	30
Start date	1 April 2023
Primary completion	1 April 2025
Estimated completion	30 April 2025
Sites	1 location across Egypt

Drugs / interventions tested

transcatheter cardiac intervention

Conditions studied

Transcatheter Neonatal Cardiac Interventions — all drugs for Transcatheter Neonatal Cardiac Interventions →

Sponsor

Sohag University

Who can join

Adults 1 Hour to 30 Days, any sex, with Transcatheter Neonatal Cardiac Interventions. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is performed to assess the safety, efficacy and outcome of transcatheter cardiac interventions in neonates with critical congenital heart disease at Sohag University Hospital

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Sohag University trials

Trials by the same sponsor.

NCT07119905 — Association Between Matrix Metalloproteinase-9 Gene Polymorphism and Susceptibility to Primary Open Angle Glaucoma Patie · not yet recruiting
NCT07512219 — Comparison Between Greater Occipital Nerve Block and Pulsed Radiofrequency in the Management of Chronic Migraine · NA · not yet recruiting
NCT07519694 — Comparative Study Between Different Additives to Lidocaine 2٪ for Peribulbar Block in Vitreoretinal Surgery · NA · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting
NCT07523386 — Compartive Study Between Cannulated Screw and Kws in Fixation of Distal Radius · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06126484 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sohag University
Last refreshed: 13 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06126484.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing